These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 26861231)

  • 21. Human Papillomavirus-Associated Oropharyngeal Cancer: Patterns of Nodal Disease.
    Plonowska KA; Strohl MP; Wang SJ; Ha PK; George JR; Heaton CM; El-Sayed IH; Mallen-St Clair J; Ryan WR
    Otolaryngol Head Neck Surg; 2019 Mar; 160(3):502-509. PubMed ID: 30274544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Residual nodal disease in patients with advanced-stage oropharyngeal squamous cell carcinoma treated with definitive radiation therapy and posttreatment neck dissection: Association with locoregional recurrence, distant metastasis, and decreased survival.
    Sandulache VC; Ow TJ; Daram SP; Hamilton J; Skinner H; Bell D; Rosenthal DI; Beadle BM; Ang KK; Kies MS; Johnson FM; El-Naggar AK; Myers JN
    Head Neck; 2013 Oct; 35(10):1454-60. PubMed ID: 23018868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lateral pharyngotomy approach in the treatment of oropharyngeal carcinoma.
    Bertolin A; Ghirardo G; Lionello M; Giacomelli L; Lucioni M; Rizzotto G
    Eur Arch Otorhinolaryngol; 2017 Jun; 274(6):2573-2580. PubMed ID: 28324180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patterns of cervical node positivity, regional failure rates, and fistula rates for HPV+ oropharyngeal squamous cell carcinoma treated with transoral robotic surgery (TORS).
    Cannon RB; Houlton JJ; Patel S; Raju S; Noble A; Futran ND; Parvathaneni U; Méndez E
    Oral Oncol; 2018 Nov; 86():296-300. PubMed ID: 30409315
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary transoral robotic surgery with concurrent neck dissection for early stage oropharyngeal squamous cell carcinoma implemented at a Danish head and neck cancer center: a phase II trial on feasibility and tumour margin status.
    Rubek N; Channir HI; Charabi BW; Lajer CB; Kiss K; Nielsen HU; Bentzen J; Friborg J; von Buchwald C
    Eur Arch Otorhinolaryngol; 2017 May; 274(5):2229-2237. PubMed ID: 28050651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of the neck after definitive chemoradiation in patients with HPV-associated oropharyngeal cancer: An institutional experience.
    Wotman M; Ghaly M; Massaro L; Tham T; Seetharamu N; Kamdar D; Frank D; Kraus D; Teckie S
    Am J Otolaryngol; 2019; 40(5):684-690. PubMed ID: 31229365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective neck dissection and deintensified postoperative radiation and chemotherapy for oropharyngeal cancer: a subset analysis of the University of Pennsylvania transoral robotic surgery trial.
    Weinstein GS; Quon H; O'Malley BW; Kim GG; Cohen MA
    Laryngoscope; 2010 Sep; 120(9):1749-55. PubMed ID: 20717944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relevance of the lymph node ratio as predictor of prognosis is higher in HPV-negative than in HPV-positive oropharyngeal squamous cell carcinoma.
    Meyer MF; Meinrath J; Seehawer J; Lechner A; Odenthal M; Quaas A; Semrau R; Huebbers CU; Marnitz S; Büttner R; Beutner D
    Clin Otolaryngol; 2018 Feb; 43(1):192-198. PubMed ID: 28714274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neck metastases in oropharyngeal cancer: Necessity and extent of bilateral treatment.
    Dziegielewski PT; O'Connell DA; Szudek J; Barber B; Joshi A; Harris JR; Seikaly H
    Head Neck; 2013 Oct; 35(10):1461-7. PubMed ID: 23008129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcomes in surgically resectable oropharynx cancer treated with transoral robotic surgery versus definitive chemoradiation.
    Dhanireddy B; Burnett NP; Sanampudi S; Wooten CE; Slezak J; Shelton B; Shelton L; Shearer A; Arnold S; Kudrimoti M; Gal TJ
    Am J Otolaryngol; 2019; 40(5):673-677. PubMed ID: 31201038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes after surgical salvage for recurrent oropharyngeal squamous cell carcinoma.
    Sweeny L; Rosenthal EL; Clemons L; Stevens TM; Cook McIntosh ER; Carroll WR
    Oral Oncol; 2016 Sep; 60():118-24. PubMed ID: 27531882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of Pathologic Extranodal Extension and Other Adverse Features After Transoral Robotic Surgery in Patients With HPV-Positive Oropharynx Cancer.
    Zebolsky AL; George E; Gulati A; Wai KC; Carpenter P; Van Zante A; Ha PK; Heaton CM; Ryan WR
    JAMA Otolaryngol Head Neck Surg; 2021 Dec; 147(12):1080-1088. PubMed ID: 34673904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heterogeneity in the clinical presentation, diagnosis, and treatment initiation of p16-positive oropharyngeal cancer.
    Raman A; Sen N; Ritz E; Fidler MJ; Revenaugh P; Stenson K; Al-Khudari S
    Am J Otolaryngol; 2019; 40(5):626-630. PubMed ID: 31174931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oncologic Outcomes Following Transoral Robotic Surgery for Human Papillomavirus-Associated Oropharyngeal Carcinoma in Older Patients.
    Parhar HS; Shimunov D; Newman JG; Cannady SB; Rajasekaran K; O' Malley BW; Chalian AA; Rassekh CH; Cohen RB; Lin A; Lukens J; Swisher-McClure S; Bauml J; Aggarwal C; Weinstein GS; Brody RM
    JAMA Otolaryngol Head Neck Surg; 2020 Dec; 146(12):1167-1175. PubMed ID: 33119091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of Lymph Node Yield on Survival in Surgically Treated Oropharyngeal Squamous Cell Carcinoma.
    Gomez ED; Chang JC; Ceremsak JJ; Brody RM; Brant JA; Rassekh CH; Weinstein GS; Newman JG
    Otolaryngol Head Neck Surg; 2021 Jan; 164(1):146-156. PubMed ID: 32689888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of transoral robotic surgery on the overall treatment of oropharyngeal cancer patients.
    Smith RV; Schiff BA; Garg M; Haigentz M
    Laryngoscope; 2015 Nov; 125 Suppl 10():S1-S15. PubMed ID: 26436491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nodal response after 46 Gy of intensity-modulated radiotherapy is associated with human papillomavirus-related oropharyngeal carcinoma.
    Dronkers EAC; Koljenovic S; Verduijn GM; Baatenburg de Jong RJ; Hardillo JAU
    Laryngoscope; 2018 Oct; 128(10):2333-2340. PubMed ID: 29521420
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is the improved prognosis of p16 positive oropharyngeal squamous cell carcinoma dependent of the treatment modality?
    Fischer CA; Zlobec I; Green E; Probst S; Storck C; Lugli A; Tornillo L; Wolfensberger M; Terracciano LM
    Int J Cancer; 2010 Mar; 126(5):1256-62. PubMed ID: 19697324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional outcomes, feasibility, and safety of resection of transoral robotic surgery: single-institution series of 35 consecutive cases of transoral robotic surgery for oropharyngeal squamous cell carcinoma.
    Lörincz BB; Möckelmann N; Busch CJ; Knecht R
    Head Neck; 2015 Nov; 37(11):1618-24. PubMed ID: 24955923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcomes of primary surgical treatment of T1 and T2 carcinomas of the oropharynx.
    Moncrieff M; Sandilla J; Clark J; Clifford A; Shannon K; Gao K; O'Brien C
    Laryngoscope; 2009 Feb; 119(2):307-11. PubMed ID: 19172611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.